A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma

NCT04601935 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Weijun Fu

Collaborators